Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Death audits and reviews for reducing maternal, perinatal and child mortality.

Willcox ML, Price J, Scott S, Nicholson BD, Stuart B, Roberts NW, Allott H, Mubangizi V, Dumont A, Harnden A.

Cochrane Database Syst Rev. 2020 Mar 25;3:CD012982. doi: 10.1002/14651858.CD012982.pub2. Review.

2.

Democracy and implementation of non-communicable disease policies - Authors' reply.

Allen LN, Goiana-da-Silva F, Nicholson BD.

Lancet Glob Health. 2020 Apr;8(4):e484. doi: 10.1016/S2214-109X(20)30033-4. No abstract available.

3.

Public preferences for using quantitative faecal immunochemical test versus colonoscopy as diagnostic test for colorectal cancer: evidence from an online survey.

von Wagner C, Verstraete W, Hirst Y, Nicholson BD, Stoffel ST, Laszlo H.

BJGP Open. 2020 Feb 4. pii: bjgpopen20X101007. doi: 10.3399/bjgpopen20X101007. [Epub ahead of print]

4.

Negotiating the risks of computed tomography in primary care.

Moreland JA, Gleeson FV, Nicholson BD.

Br J Gen Pract. 2020 Jan 30;70(691):86-87. doi: 10.3399/bjgp20X708029. Print 2020 Feb. No abstract available.

PMID:
32001475
5.

Bridging the gap between care: is speed dating the answer?

Harrison S, Nekhlyudov L, Bell D, Bowdage S, Nicholson BD.

Br J Gen Pract. 2020 Jan 30;70(691):73. doi: 10.3399/bjgp20X707513. Print 2020 Feb. No abstract available. Erratum in: Br J Gen Pract. 2020 Feb 27;70(692):111.

PMID:
32001462
6.

Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.

Allen LN, Nicholson BD, Yeung BYT, Goiana-da-Silva F.

Lancet Glob Health. 2020 Jan;8(1):e50-e58. doi: 10.1016/S2214-109X(19)30446-2. Epub 2019 Dec 5.

7.

Determinants and extent of weight recording in UK primary care: an analysis of 5 million adults' electronic health records from 2000 to 2017.

Nicholson BD, Aveyard P, Bankhead CR, Hamilton W, Hobbs FDR, Lay-Flurrie S.

BMC Med. 2019 Nov 29;17(1):222. doi: 10.1186/s12916-019-1446-y.

8.

Quality improvements of safety-netting guidelines for cancer in UK primary care: insights from a qualitative interview study of GPs.

Tompson A, Nicholson BD, Ziebland S, Evans J, Bankhead C.

Br J Gen Pract. 2019 Nov 28;69(689):e819-e826. doi: 10.3399/bjgp19X706565. Print 2019 Dec.

PMID:
31685542
9.

Experience of adopting faecal immunochemical testing to meet the NICE colorectal cancer referral criteria for low-risk symptomatic primary care patients in Oxfordshire, UK.

Nicholson BD, James T, East JE, Grimshaw D, Paddon M, Justice S, Oke JL, Shine B.

Frontline Gastroenterol. 2019 Oct;10(4):347-355. doi: 10.1136/flgastro-2018-101052. Epub 2018 Oct 9.

PMID:
31656559
10.

When should unexpected weight loss warrant further investigation to exclude cancer?

Nicholson BD, Aveyard P, Hamilton W, Hobbs FDR.

BMJ. 2019 Sep 23;366:l5271. doi: 10.1136/bmj.l5271. No abstract available.

PMID:
31548272
11.

How do GPs and patients share the responsibility for cancer safety netting follow-up actions? A qualitative interview study of GPs and patients in Oxfordshire, UK.

Evans J, Macartney JI, Bankhead C, Albury C, Jones D, Ziebland S, Nicholson BD.

BMJ Open. 2019 Sep 12;9(9):e029316. doi: 10.1136/bmjopen-2019-029316.

12.

General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey.

Von Wagner C, Stoffel ST, Freeman M, Laszlo HE, Nicholson BD, Sheringham J, Szinay D, Hirst Y.

BMJ Open. 2019 Apr 11;9(4):e025737. doi: 10.1136/bmjopen-2018-025737.

13.

Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.

Shinkins B, Primrose JN, Pugh SA, Nicholson BD, Perera R, James T, Man D.

Br J Surg. 2019 May;106(6):728. doi: 10.1002/bjs.11175. No abstract available.

PMID:
30973997
14.

Patient consultation rate and clinical and NHS outcomes: a cross-sectional analysis of English primary care data from 2.7 million patients in 238 practices.

Lay-Flurrie S, Mathieu E, Bankhead C, Nicholson BD, Perera-Salazar R, Holt T, Hobbs FDR, Salisbury C; NIHR School for Primary Care Research, Nuffield Department of Primary Care Health Sciences, University of Oxford.

BMC Health Serv Res. 2019 Apr 6;19(1):219. doi: 10.1186/s12913-019-4036-y.

15.

Faecal immunochemical (rule-in) testing in general practice.

Bailey SE, van Melle MA, Nicholson BD.

Br J Gen Pract. 2019 Apr;69(681):178. doi: 10.3399/bjgp19X702173. No abstract available.

16.

The internal validation of weight and weight change coding using weight measurement data within the UK primary care Electronic Health Record.

Nicholson BD, Aveyard P, Hamilton W, Bankhead CR, Koshiaris C, Stevens S, Hobbs FD, Perera R.

Clin Epidemiol. 2019 Jan 25;11:145-155. doi: 10.2147/CLEP.S189989. eCollection 2019.

17.

The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review.

Nicholson BD, Jones NR, Protheroe A, Joseph J, Roberts NW, Van den Bruel A, Fanshawe TR.

Cancer Epidemiol. 2019 Apr;59:15-21. doi: 10.1016/j.canep.2019.01.001. Epub 2019 Jan 15.

PMID:
30658216
18.

National cancer control plans.

Nicholson BD, Shinkins B, Price S, Verbakel JY, Merriel S; Society of Academic Primary Care Cancer Special Interest Group.

Lancet Oncol. 2018 Dec;19(12):e665. doi: 10.1016/S1470-2045(18)30830-1. No abstract available.

PMID:
30507425
19.

The elusive diagnosis of cancer: testing times.

Nicholson BD, Perera R, Thompson MJ.

Br J Gen Pract. 2018 Nov;68(676):510-511. doi: 10.3399/bjgp18X699461. No abstract available. Erratum in: Br J Gen Pract. 2019 Apr;69(681):178.

20.

Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.

von Wagner C, Stoffel S, Freeman M, Laszlo H, Nicholson BD, Sheringham J, Szinay D, Hirst Y.

Br J Gen Pract. 2018 Nov;68(676):e757-e764. doi: 10.3399/bjgp18X699413. Epub 2018 Oct 8.

21.

The mapping of cancer incidence and mortality trends in the UK from 1980-2013 reveals a potential for overdiagnosis.

Oke JL, O'Sullivan JW, Perera R, Nicholson BD.

Sci Rep. 2018 Oct 2;8(1):14663. doi: 10.1038/s41598-018-32844-x.

22.

Trends in Cancer Antigen 125 testing 2003-2014: A primary care population-based cohort study using laboratory data.

Nicholson BD, Lee MM, Wijeratne D, James T, Shine B, Oke JL.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12914. doi: 10.1111/ecc.12914. Epub 2018 Sep 20.

PMID:
30238522
23.

Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Smith CF, Tompson AC, Jones N, Brewin J, Spencer EA, Bankhead CR, Hobbs FR, Nicholson BD.

Br J Gen Pract. 2018 Sep;68(674):e594-e603. doi: 10.3399/bjgp18X698561. Epub 2018 Aug 13.

24.

Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care.

Koshiaris C, Van den Bruel A, Oke JL, Nicholson BD, Shephard E, Braddick M, Hamilton W.

Br J Gen Pract. 2018 Sep;68(674):e586-e593. doi: 10.3399/bjgp18X698357. Epub 2018 Aug 13.

25.

General practitioner referrals to one-stop clinics for symptoms that could be indicative of cancer: a systematic review of use and clinical outcomes.

Friedemann Smith C, Tompson A, Holtman GA, Bankhead C, Gleeson F, Lasserson D, Nicholson BD.

Fam Pract. 2019 May 23;36(3):255-261. doi: 10.1093/fampra/cmy069.

26.

Medications that reduce emergency hospital admissions: an overview of systematic reviews and prioritisation of treatments.

Bobrovitz N, Heneghan C, Onakpoya I, Fletcher B, Collins D, Tompson A, Lee J, Nunan D, Fisher R, Scott B, O'Sullivan J, Van Hecke O, Nicholson BD, Stevens S, Roberts N, Mahtani KR.

BMC Med. 2018 Jul 26;16(1):115. doi: 10.1186/s12916-018-1104-9. Review.

27.

Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis.

Koshiaris C, Oke J, Abel L, Nicholson BD, Ramasamy K, Van den Bruel A.

BMJ Open. 2018 Jun 22;8(6):e019758. doi: 10.1136/bmjopen-2017-019758.

28.

GPs' understanding and practice of safety netting for potential cancer presentations: a qualitative study in primary care.

Evans J, Ziebland S, MacArtney JI, Bankhead CR, Rose PW, Nicholson BD.

Br J Gen Pract. 2018 Jul;68(672):e505-e511. doi: 10.3399/bjgp18X696233. Epub 2018 May 8.

29.

Responsibility for follow-up during the diagnostic process in primary care: a secondary analysis of International Cancer Benchmarking Partnership data.

Nicholson BD, Goyder CR, Bankhead CR, Toftegaard BS, Rose PW, Thulesius H, Vedsted P, Perera R.

Br J Gen Pract. 2018 May;68(670):e323-e332. doi: 10.3399/bjgp18X695813. Epub 2018 Apr 23.

30.

Weight loss as a predictor of cancer in primary care: a systematic review and meta-analysis.

Nicholson BD, Hamilton W, O'Sullivan J, Aveyard P, Hobbs FR.

Br J Gen Pract. 2018 May;68(670):e311-e322. doi: 10.3399/bjgp18X695801. Epub 2018 Apr 9.

31.

Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.

Shinkins B, Primrose JN, Pugh SA, Nicholson BD, Perera R, James T, Mant D.

Br J Surg. 2018 May;105(6):658-662. doi: 10.1002/bjs.10819. Epub 2018 Mar 26. Erratum in: Br J Surg. 2019 May;106(6):728.

32.

Overtesting and undertesting in primary care: a systematic review and meta-analysis.

O'Sullivan JW, Albasri A, Nicholson BD, Perera R, Aronson JK, Roberts N, Heneghan C.

BMJ Open. 2018 Feb 11;8(2):e018557. doi: 10.1136/bmjopen-2017-018557. Review.

33.

The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer.

Nicholson BD, Oke J, Friedemann Smith C, Phillips JA, Lee J, Abel L, Kelly S, Gould I, Mackay T, Kaveney Z, Anthony S, Hayles S, Lasserson D, Gleeson F.

BMJ Open. 2018 Jan 21;8(1):e018168. doi: 10.1136/bmjopen-2017-018168.

34.

Weight loss as a predictor of cancer and serious disease in primary care: an ISAC-approved CPRD protocol for a retrospective cohort study using routinely collected primary care data from the UK.

Nicholson BD, Aveyard P, Hobbs FDR, Smith M, Fuller A, Perera R, Hamilton W, Stevens S, Bankhead CR.

Diagn Progn Res. 2018 Jan 10;2:1. doi: 10.1186/s41512-017-0019-9. eCollection 2018.

35.

Point-of-care Helicobacter pylori testing: primary care technology update.

Nicholson BD, Abel LM, Turner PJ, Price CP, Heneghan C, Hayward G, Plüddemann A.

Br J Gen Pract. 2017 Dec;67(665):576-577. doi: 10.3399/bjgp17X693881. No abstract available.

36.

Identifying clinical features in primary care electronic health record studies: methods for codelist development.

Watson J, Nicholson BD, Hamilton W, Price S.

BMJ Open. 2017 Nov 22;7(11):e019637. doi: 10.1136/bmjopen-2017-019637.

37.

What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.

Shinkins B, Nicholson BD, James T, Pathiraja I, Pugh S, Perera R, Primrose J, Mant D.

Health Technol Assess. 2017 Apr;21(22):1-60. doi: 10.3310/hta21220. Review.

38.

Detecting cancer in primary care: Where does early diagnosis stop and overdiagnosis begin?

Nicholson BD.

Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12692. Epub 2017 Apr 20. No abstract available.

PMID:
28426170
39.

Can safety-netting improve cancer detection in patients with vague symptoms?

Nicholson BD, Mant D, Bankhead C.

BMJ. 2016 Nov 9;355:i5515. doi: 10.1136/bmj.i5515. No abstract available.

PMID:
28291732
40.

The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.

Shinkins B, Nicholson BD, Primrose J, Perera R, James T, Pugh S, Mant D.

PLoS One. 2017 Mar 10;12(3):e0171810. doi: 10.1371/journal.pone.0171810. eCollection 2017.

41.

The Sore Throat Test and Treat Service: speed should not substitute science.

Goyder C, Verbakel J, Hayward G, Lee J, Nicholson BD, Van den Bruel A.

Br J Gen Pract. 2017 Mar;67(656):110. doi: 10.3399/bjgp17X689545. No abstract available.

42.

Economic and clinical burden of opioid-induced nausea and vomiting.

Nicholson BD.

Postgrad Med. 2017 Jan;129(1):111-117. doi: 10.1080/00325481.2017.1243004. Epub 2016 Oct 11. Review.

PMID:
27690715
43.

Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer.

Nicholson BD, Shinkins B, Mant D.

JAMA. 2016 Sep 27;316(12):1310-1. doi: 10.1001/jama.2016.11212.

PMID:
27673308
44.

Variation in Direct Access to Tests to Investigate Cancer: A Survey of English General Practitioners.

Nicholson BD, Oke JL, Rose PW, Mant D.

PLoS One. 2016 Jul 22;11(7):e0159725. doi: 10.1371/journal.pone.0159725. eCollection 2016.

45.

International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.

Nicholson BD, Mant D, Neal RD, Hart N, Hamilton W, Shinkins B, Rubin G, Rose PW.

Br J Gen Pract. 2016 Feb;66(643):e106-13. doi: 10.3399/bjgp16X683449. Epub 2016 Jan 6.

46.

Blood CEA levels for detecting recurrent colorectal cancer.

Nicholson BD, Shinkins B, Pathiraja I, Roberts NW, James TJ, Mallett S, Perera R, Primrose JN, Mant D.

Cochrane Database Syst Rev. 2015 Dec 10;(12):CD011134. doi: 10.1002/14651858.CD011134.pub2. Review.

47.

Comment on: 'Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960'--cancer predictions need more context.

Oke JL, Nicholson BD, Shinkins B.

Br J Cancer. 2015 Dec 1;113(11):1632. doi: 10.1038/bjc.2015.219. Epub 2015 Jun 23. No abstract available.

48.

Assessing the appropriateness of information on childhood fever in thermometer package leaflets: a systematic audit of thermometers available in the UK.

Hernandez J, Nicholson BD, Thompson M.

Br J Gen Pract. 2015 Jun;65(635):e366-71. doi: 10.3399/bjgp15X685261.

49.

Home-use faecal immunochemical testing: primary care diagnostic technology update.

Nicholson BD, Thompson M, Price CP, Heneghan C, Plüddemann A.

Br J Gen Pract. 2015 Mar;65(632):156-8. doi: 10.3399/bjgp15X684229. Review. No abstract available.

50.

Supplemental Content

Loading ...
Support Center